Iqvia has led a $15m series C round for MIT-founded genomic data analytics spinout BC Platforms as part of a strategic partnership agreement.
BC Platforms, a Switzerland-based genomic data management and analytics spinout of Massachusetts Institute of Technology, closed a $15m series C financing round today led by medical services outsourcing company Iqvia as part of a strategic collaboration.
The round was backed by Debiopharm Innovation Fund, a strategic investment vehicle of biopharmaceutical development group Debiopharm, and was filled out by Finnish government-owned investment firm Finnish Industry Investment (Tesi).
Founded in 1997, BC Platforms provides pharmaceutical developers with genomic data management…